Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125555762 | 12555576 | 2 | F | 20160719 | 20160714 | 20160729 | EXP | GB-MHRA-ADR 23536692 | GB-TEVA-674249ACC | TEVA | 57.00 | YR | M | Y | 79.00000 | KG | 20160729 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125555762 | 12555576 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | Y | U | 62497 | 100 | MG | |||||||
| 125555762 | 12555576 | 2 | SS | WARFARIN | WARFARIN | 1 | Oral | Y | U | 40145 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125555762 | 12555576 | 1 | Lower respiratory tract infection |
| 125555762 | 12555576 | 2 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125555762 | 12555576 | HO |
| 125555762 | 12555576 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125555762 | 12555576 | Abdominal wall haematoma | |
| 125555762 | 12555576 | Drug interaction | |
| 125555762 | 12555576 | International normalised ratio abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125555762 | 12555576 | 1 | 20160523 | 20160529 | 0 | |
| 125555762 | 12555576 | 2 | 20160528 | 0 |